Takahiro Katagiri

Discovery of DS79932728: A Potent, Orally Available G9a/GLP Inhibitor for Treating β-Thalassemia and Sickle Cell Disease

Katsushi Katayama, Ken J. Ishii, Hideki Terashima et al. · ACS Medicinal Chemistry Letters · 2020 · 27 citations · Full text

Medicine, Genetics, Pharmacology +12

Discovery of novel histone lysine methyltransferase G9a/GLP (EHMT2/1) inhibitors: Design, synthesis, and structure-activity relationships of 2,4-diamino-6-methylpyrimidines

Katsushi Katayama, Ken J. Ishii, Keiichi Yotsumoto et al. · Bioorganic & Medicinal Chemistry Letters · 2020 · 24 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13

Synthesis and Relative Stereochemistry of the A- and F-Rings of Goniodomin A

Kenshu Fujiwara, Jota Naka, Takahiro Katagiri et al. · Bulletin of the Chemical Society of Japan · 2007 · 21 citations

Natural Sciences, Biochemistry, Chemistry +10

Synthesis of the ABC-ring models of goniodomin A: preference for the unnatural configuration at C11 of the BC-ring in a non-macrocyclic model system

Takahiro Katagiri, Kenshu Fujiwara, Hidetoshi Kawai et al. · Tetrahedron Letters · 2008 · 20 citations

Natural Sciences, Medicinal Chemistry, Biomolecular Modeling +7

Synthesis of the DE-ring of goniodomin A and prediction of its natural relative stereochemistry

Takahiro Katagiri, Kenshu Fujiwara, Hidetoshi Kawai et al. · Tetrahedron Letters · 2007 · 17 citations

Natural Sciences, Chemistry, Medicinal Chemistry +8